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Leukocyte adhesion to the extracellular matrix (ECM) is tightly controlled and is vital for the immune
response. Circulating lymphocytes leave the bloodstream and adhere to ECM components at sites of inflam-
mation and lymphoid tissues. Mechanisms for regulating T-lymphocyte–ECM adhesion include (i) an alter-
ation in the affinity of cell surface integrin receptors for their extracellular ligands and (ii) an alteration of
events following postreceptor occupancy (e.g., cell spreading). Whereas H-Ras and R-Ras were previously
shown to affect T-cell adhesion by altering the affinity state of the integrin receptors, no signaling molecule has
been identified for the second mechanism. In this study, we demonstrated that expression of an activated
mutant of Rac triggered dramatic spreading of T cells and their increased adhesion on immobilized fibronectin
in an integrin-dependent manner. This effect was not mimicked by expression of activated mutant forms of
Rho, Cdc42, H-Ras, or ARF6, indicating the unique role of Rac in this event. The Rac-induced spreading was
accompanied by specific cytoskeletal rearrangements. Also, a clustering of integrins at sites of cell adhesion
and at the peripheral edges of spread cells was observed. We demonstrate that expression of RacV12 did not
alter the level of expression of cell surface integrins or the affinity state of the integrin receptors. Moreover, our
results indicate that Rac plays a role in the regulation of T-cell adhesion by a mechanism involving cell
spreading, rather than by altering the level of expression or the affinity of the integrin receptors. Furthermore,
we show that the Rac-mediated signaling pathway leading to spreading of T lymphocytes did not require
activation of c-Jun kinase, serum response factor, or pp70S6 kinase but appeared to involve a phospholipid
kinase.
T lymphocytes primarily circulate in the vascular system
until they receive signals which trigger their enhanced adhe-
sion to extracellular matrix (ECM) components, such as fi-
bronectin, collagen, and laminin, or to vascular endothelium.
The adherence of T cells to ECM components is a prerequisite
for their migration into sites of inflammation (7, 10, 45, 47).
Key regulators of these adhesion events are members of het-
erodimeric cell adhesion receptors, known as integrins (24).
Integrin receptors are composed of a and b subunits, and each
subunit consists of a large extracellular domain which is in-
volved in ligand recognition, a transmembrane region, and a
short cytoplasmic domain. The major integrin receptors for
fibronectin on peripheral blood mononuclear cells, a4b1 and
a5b1, have been shown to be involved in the migration of
lymphoid cells into sites of inflammation (17, 20, 26). Two
physiological mechanisms have been described for controlling
the adhesion of T lymphocytes to the ECM (16, 45). One
mechanism involves the modulation of the affinity of cell sur-
face integrin receptors for ECM proteins. Divalent cations
such as Mg21, Mn21, and Ca21 and certain anti-integrin
monoclonal antibodies (MAbs) have been shown to induce an
increase in integrin affinity (47). The second mechanism in-
volves an alteration of events following postreceptor occu-
pancy without affecting receptor affinity, such as cell spreading
and/or integrin clustering. For example, treatment with phor-
bol esters stimulated the a5b1-dependent adhesion of T cells
onto fibronectin without alteration of the fibronectin receptor
binding affinity (16). In the latter case, increased cell adhesion
was dependent on the actin cytoskeleton and cell spreading.
One advantage of cell spreading is that it provides a more
streamlined shape to T cells and thereby reduces the shear
imposed on them by the vascular flow in the venules. Little is
known about the signaling components which are directly in-
volved in this latter mechanism of T-lymphocyte adhesion.
Members of the Rho subfamily of the Ras-related GTP-
binding proteins play a crucial role in the regulation of cy-
toskeletal organization and associated focal complex formation
in response to extracellular growth factors. The Rho subfamily
consists of several members, including Rho, Rac, and Cdc42,
which cycle between the active GTP-bound state and the in-
active GDP-bound state (reviewed in reference 49). In fibro-
blasts, it has been demonstrated that activation of Rho by
extracellular growth factors such as lysophosphatidic acid
(LPA) and bombesin triggers the formation of actin stress
fibers and focal adhesion complexes (39), whereas activation of
Rac (for example, by platelet-derived growth factor, epidermal
growth factor, or insulin) elicits actin polymerization at the
plasma membrane to produce lamellipodia and membrane ruf-
fles (40). Activation of Cdc42 triggered the formation of filopo-
dial protrusions and microspikes at the cell periphery (31, 36).
Both Rac and Cdc42 have also been shown to induce the
assembly of multimolecular focal complexes at the plasma
membrane of fibroblasts (36). Studies by Hotchin and Hall (22)
demonstrated the importance of the Rho family GTPases in
regulating integrin clustering and subsequent interaction of
integrins with focal adhesion and signaling molecules. They
showed that attachment of fibroblast cells to the ECM is not
sufficient to induce clustering of integrins and focal complex
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formation but requires the activity of the Rho GTPases, in
particular Rho and Rac. Over the past few years, there has
been increasing evidence that the Rho GTPases play crucial
roles in other cellular events such as membrane trafficking,
transcriptional regulation, cell growth control, and develop-
ment (19, 38, 49).
Here, we have examined the role of the Rho family GTPases
in T-lymphocyte adhesion. We demonstrate that an activated
mutant form of Rac, but not of Rho or Cdc42, induces spread-
ing and an increase in adhesion of T cells onto immobilized
fibronectin in an integrin-dependent manner. We further show
that expression of RacV12 did not alter the level of expression
of integrins or their affinity state, indicating that Rac contrib-
utes to T-cell adhesion through events following postreceptor
occupancy. Finally, we demonstrate that activation of c-Jun
kinase (JNK), serum response factor (SRF), or pp70S6 kinase is
not essential for Rac-induced T-cell spreading, but that the
latter appears to involve a phospholipid kinase.
MATERIALS AND METHODS
Antibodies and reagents. Spliced fibronectin fragments, p100FN and p33FN,
and antibodies against a4 and a5 integrins were kindly provided by J. Schorey
and E. Brown (Washington University, St. Louis, Mo.). MAb 15/7, which inter-
acts selectively with b1 integrins in the high-affinity state, was a generous gift
from Ted Yednock (Athena Neurosciences); the activating MAb 8A2 was kindly
provided by Nick Kovach (University of Washington, Seattle). Fluorescein iso-
thiocyanate (FITC)-conjugated anti-a5 antibodies were obtained from Immuno-
tech (Westbrook, Maine), phycoerythrin (PE)-conjugated anti-a4 and anti-b1
antibodies were from Pharmingen (San Diego, Calif.), and FITC-conjugated
anti-CD69 MAb and PerCP-conjugated MAbs against CD20 were from Becton
Dickinson (Bedford, Mass.). Unlabeled fibronectin was purchased from Becton
Dickinson, and 125I-labeled fibronectin was from ICN (Irvine, Calif.). FITC-
labeled secondary antibodies used for immunofluorescence studies were ob-
tained from Cappel (Durham, N.C.), and rhodamine phalloidin was from Mo-
lecular Probes (Eugene, Oreg.). Antibodies against T7 epitope and H-Ras were
purchased from Novagen and Oncogene, respectively. Antibodies against ARF6
were raised against glutathione S-transferase–ARF6 (15), and antibodies against
RhoA were purchased from Santa Cruz Biotechnology. Wortmannin, LY294002,
and rapamycin were purchased from Calbiochem (La Jolla, Calif.), and nocoda-
zole, cytochalasin D, deoxyglucose, and sodium azide were obtained from Sigma
Chemical Co. (St. Louis, Mo.).
Cells, plasmids, and DNA transfection. Jurkat T-cell lines JJK CD41 (gener-
ous gift from J. Skowronski, Cold Spring Harbor Laboratory [CSHL]) and E6-1
(American Type Culture Collection) and Molt-4 cells (CSHL) were maintained
in RPMI 1640 medium supplemented with 2 mM glutamine, 5 mM antibiotics, 20
mM HEPES (pH 7.4), and 10% fetal bovine serum. Plasmids encoding various
cDNAs were transfected into T cells by using an electroporation protocol as
previously described (25). Briefly, aliquots of 107 cells from exponentially grow-
ing cultures were electroporated at 200 V and 960 mF with a total of 25 mg of
DNA containing various amounts of appropriate plasmids as indicated and
pBluescript as carrier DNA. To evaluate the transfection efficiencies and the
number of RacV12,N33-expressing cells that are spread, we transfected 107 cells
with an expression plasmid encoding the green fluorescent protein (pCG-GFP)
(gift from J. Skowronski and G. Pavlakis [National Institutes of Health]). The
transfection efficiencies usually vary between 25 and 40% of the total viable cells.
For flow cytometry analysis, 2 mg expression plasmid pCMV-CD20 was cotrans-
fected for use as a marker of transfected cells. The amount of pCMV-CD20 was
kept relatively low to ensure that the CD20 reporter was coexpressed with the
RacV12,N33 protein in the majority of CD20-positive cells. The mammalian
expression plasmids, pCGT-RacV12, pCGT-RacV12,L37, pCGT-RacV12,H40,
pCGT-RacV12,N33, pcDNA3-ARF6(Q67L), used in these studies have been
previously described (14, 28, 55). pDCR-HRasV12 and pDCR-HRasN17 were a
generous gift of C. Nicolette (CSHL). The expression plasmids pCGT-
Cdc42V12, pCGT-Cdc42N17, and pCGT-RhoV14 were obtained by PCR am-
plification of mutant cDNAs (plasmids kindly provided by Alan Hall) and cloned
into XbaI/BamHI restriction sites of pCGT. pcDNA3-ARF6T27N was ob-
tained by PCR amplification and cloned into the EcoRI site of pcDNA.
pcEXV-RhoN19, pCMV-CD20, and the constitutively active phosphatidyl-
inositol 3-kinase (PI3 kinase) catalytic p110 subunit (p110aCAAX) were a
generous gift from M. Symons (Onyx Pharmaceuticals), J. Skowronski, and J.
Downward (Imperial Cancer Research Fund, London, England), respec-
tively.
Cell spreading and adhesion. Jurkat cells transfected with indicated plasmids
were seeded onto fibronectin- or poly-L-lysine-coated dishes or coverslips. Cells
were viewed with a light microscope, and phase-contrast images of the cells were
generated with a Canon camera. For quantitation of cell adhesion, 24 h post-
transfection, unattached cells were rinsed off and the total numbers of adherent
cells and spread cells were determined. Flattened cells with protrusions along
the edges that exhibited a fibroblast-like morphology were counted as spread
cells.
Flow cytometry analysis. To measure the expression level of integrins, approx-
imately 24 h following electroporation, aliquots of 1.5 3 106 Jurkat T cells
cotransfected with either 10 mg of RacV12,N33 or empty vector and 2 mg of
pCMV-CD20 were washed once with phosphate-buffered saline containing 1%
fetal bovine serum and 0.1% sodium azide (PBS-FS). Cells were resuspended
and incubated in 100-ml aliquots of a cocktail containing 4 ml of PerCP-conju-
gated MAb against CD20 together with 15 ml of R-PE-conjugated anti-a4 MAb,
20 ml of FITC-conjugated anti-CD69 MAb, and a cocktail containing 4 ml of
PerCP-conjugated anti-CD20 together with 20 ml of R-PE-conjugated anti-b1
MAb and 20 ml of anti-a5 MAb for 1 h. The antibodies were titrated to obtain
the optimal concentrations. Similarly for the integrin affinity experiments, 1.5 3
106 Jurkat T cells were cotransfected with either 10 mg of RacV12,N33 or empty
vector and 2 mg of pCMV-CD20, washed as described above, and resuspended
in 100-ml aliquots of PBS-FS containing 4 ml of PerCP-conjugated anti-CD20 and
MAb 15/7 (0.5 mg/ml) for 1 h. The activating antibody 8A2 was included as
positive control. Cells were then washed three times with PBS-FS and resus-
pended in 200 ml of PBS-FS. In the case of anti-a5, CD69, and 15/7 MAbs, cells
were subsequently treated with FITC-labeled secondary antibody (including goat
anti-mouse immunoglobulin G [IgG] as a control) for 30 min and washed again
three times. Expression of the integrin receptors on the cell surface was analyzed
on an Epics-Elite flow cytometer.
Soluble fibronectin binding assay. Cells transfected with 10 mg of either empty
vector or RacV12,N33 or cells treated with antibody 8A2 (20 ng/ml) were serum
starved, seeded onto fibronectin-coated dishes, and incubated at 37°C overnight.
Since we usually obtained an average transfection efficiency of between 25 and
40%, we used 40% 8A2-treated Jurkat cells mixed with 60% untreated cells.
Adherent cells were detached from the dish by brief treatment with trypsin-
EDTA; 2 3 106 cells (for each experimental condition) were washed and resus-
pended in serum-free medium and then incubated in RPMI medium containing
0.02% bovine serum albumin and radiolabeled 125I fibronectin, or in the same
medium but with increasing amounts of unlabeled fibronectin, at room tem-
perature for 1 h. Bound radioactivity was measured as previously described
(44).
Immunofluorescent staining. Jurkat cells transfected with the indicated plas-
mids were seeded onto fibronectin- or poly-L-lysine-coated coverslips. At 16 to
20 h posttransfection, cells were rinsed and the adherent cells were fixed, per-
meabilized, and labeled with primary and secondary antibodies as previously
described (15). Actin filament organization was visualized by staining the fixed
cells with rhodamine phalloidin for 2 h after permeabilization. Coverslips were
washed, mounted, and viewed as previously described (15).
Western immunoblotting. After electroporation, Jurkat cells transfected with
indicated plasmids were resuspended in 10 ml of RPMI medium; 3 ml was plated
on fibronectin-coated dishes, and the remaining 7 ml was used to prepare lysates.
Cell lysates were subjected to sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred to nitrocellulose membranes, and pro-
teins were visualized with an enhanced chemiluminescence detection system
(Amersham) by using goat anti-mouse or goat anti-rabbit peroxidase-conjugated
secondary antibodies.
RESULTS
Constitutively active Rac, RacV12, triggers T-lymphocyte
spreading and an increase in adhesion. To examine the in-
volvement of the members of the Rho subfamily of small
GTPases in T-lymphocyte adhesion, a Jurkat T-cell line, JJK
CD41, was transfected with expression plasmids encoding T7-
tagged constitutively activated mutant forms of Rac, Rho, and
Cdc42, i.e., RacV12, RhoV14, and Cdc42V12, respectively,
and their ability to adhere to immobilized matrix proteins was
assessed. Expression of these mutants was confirmed by im-
munoblotting (data not shown). We observed that when plated
on fibronectin-coated dishes, RacV12 (but not Cdc42V12 or
RhoV14)-transfected cells exhibited a dramatic spread pheno-
type and numerous surface protrusions (Fig. 1A). This re-
sponse was detected as early as 4 h after transfection and was
restricted to cells expressing RacV12, as confirmed by immu-
nofluorescence staining (Fig. 1B). No spread phenotype was
observed when RacV12-transfected cells were plated on poly-
L-lysine-coated dishes (Fig. 1B). Interestingly, a Rac mutant,
RacV12,N33, that was previously isolated in a two-hybrid
screen designed to identify effector domain mutants which
display differential binding to Rac effector proteins (55) in-
duced cell spreading onto fibronectin more potently than
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RacV12 (Fig. 1A). Hence, we resorted to the use of this mu-
tant in order to investigate the mechanism of Rac induced
T-cell spreading and adhesion. We found that 4 to 6 h post-
transfection, approximately 10 to 20% of the viable cells
showed the spread phenotype; the number of spread cells
increased gradually with time and reached a maximum (ca. 30
to 40%) at 16 to 20 h posttransfection. At this point, all
RacV12,N33-expressing cells exhibited a spread phenotype. To
determine whether RacV12,N33-induced cell spreading was
associated with an increase in adhesion, RacV12,N33-trans-
fected cells were seeded onto fibronectin-coated dishes; 16 h
posttransfection, nonadherent cells were rinsed off and the
number of adherent cells was determined. Notably, all spread
cells remained adhered to the dish, and as shown in Table 1,
the total number of adherent cells was consistently 25 to 35%
higher in the dish containing the RacV12,N33-transfected cells
than in the dish transfected with vector alone. This dramatic
spreading and increase in adhesion onto immobilized fibronec-
tin was also observed when RacV12,N33 was expressed in
other lymphocyte cell lines such as Molt-4, H9, and the Jurkat
line E6-1 (data not shown). These results suggest that Rac
contributes to T-cell adhesion on immobilized fibronectin most
likely through a mechanism involving cell spreading. In addi-
tion to fibronectin, spreading of RacV12,N33-expressing cells,
although to a lesser extent, was also observed on collagen but
not on laminin (data not shown).
FIG. 1. Rac induces T-lymphocyte spreading. (A) The Jurkat T-cell line JJK CD41 was transfected with 5 mg of vector DNA or expression plasmids encoding either
RacV12, RhoV14, Cdc42V12, or RacV12,N33 and seeded on fibronectin-coated tissue culture dishes. Six hours posttransfection, cells were visualized using a light
microscope and photographed with a Canon camera. (B) RacV12,N33-transfected cells were seeded on fibronectin (upper panel)- or poly-L-lysine (lower panel)-coated
coverslips. Cells were fixed and labeled with anti-T7 MAb followed by goat anti-mouse IgG coupled to FITC (right panel). Cells were also stained with rhodamine
phalloidin to visualize actin organization (left panel). Only RacV12,N33-transfected cells exhibited the spread phenotype when plated on fibronectin-coated coverslips.
Bar 5 10 mm.
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Rac-induced spreading and increased adhesion on immobi-
lized fibronectin are mediated by a4b1 and a5b1 integrins.
Since adhesion of leukocytes to the ECM is primarily mediated
by integrin-ECM interactions and since a4b1 and a5b1 dimers
are the principal fibronectin receptors expressed on peripheral
blood mononuclear cells (20), we sought to examine whether
RacV12-induced spreading and enhanced adhesion on immo-
bilized fibronectin were mediated by integrin receptors. There-
fore, we tested the ability of antibodies directed against a4, a5,
b1, and a2 integrins to block RacV12,N33-elicited spreading
and enhanced adhesion by pretreating transfected cells with
anti-integrin antibody prior to seeding them on fibronectin-
coated coverslips. As shown in Fig. 2A, antibodies against a4
and b1 completely abolished cell spreading, whereas antibod-
ies against a5 (Fig. 2A) and a2 (not shown) had no apparent
effect. Also, pretreatment of RacV12,N33-transfected cells
with antibodies against a4 and b1 abolished the increased
adhesion, as determined by counting the total adherent cells
(data not shown). To confirm that the RacV12,N33-induced
effect was mediated by a4b1, we tested the ability of
RacV12,N33-expressing cells to spread and promote adhesion
on spliced fibronectin fragments p33FN, an alternative spliced
V region that specifically recognizes a4b1 (18, 53), and
p100FN, the central domain of fibronectin containing the
RGDS motif that interacts specifically with a5b1 (23, 42).
Surprisingly, RacV12,N33-expressing cells spread onto both
fibronectin fragments. Antibodies against a4 blocked spread-
ing on p33FN, whereas those against a5 did not (Fig. 2C).
Conversely, antibodies against a5 inhibited cell spreading on
p100FN, whereas antibodies against a4 had no effect (Fig. 2B).
Similar results were obtained when we evaluated T-cell adhe-
sion on the above-described spliced fibronectin fragments
(data not shown). These results indicate that RacV12,N33-
induced spreading and enhanced adhesion on immobilized fi-
bronectin are mediated predominantly by a4b1 integrins; how-
ever, the a5b1 integrins can also contribute to this adhesion
mechanism.
Rac-induced cell spreading is accompanied with cytoskel-
etal rearrangements and integrin clustering. The observation
that RacV12,N33-expressing cells exhibited cytoskeletal rear-
rangements (Fig. 3A) prompted us to investigate whether
Rac’s effect on cell spreading is dependent on actin polymer-
ization. To this end, we tested the effect of cytochalasin D, an
inhibitor of actin polymerization, on RacV12,N33-induced cell
spreading. As shown in Fig. 3A, pretreatment of RacV12,N33-
expressing cells with cytochalasin D abolished cell spreading.
Since the increase in adhesion appeared to be associated with
an increase in cell spreading (Table 1), we examined whether
pretreatment of RacV12,N33-expressing cells with cytochala-
sin D also interfered with the increased adhesion. As shown in
Table 1, cytochalasin D abrogated the increase in adhesion,
indicating that Rac-induced cell spreading and enhanced ad-
hesion were dependent on the actin cytoskeleton. Evidence
supporting the importance of Rac-elicited cytoskeletal rear-
rangements in mediating cell spreading came from our studies
using mutant forms of the GTPases Rho, ARF6, Cdc42 and
H-Ras, all of which have been shown to induce cytoskeletal
rearrangements (6, 14, 31, 36, 39). For these studies, Jurkat
cells were cotransfected with mutant forms of each of these
GTPases and RacV12,N33 and then seeded on fibronectin-
coated tissue culture dishes. Coexpression of dominant nega-
tive mutants of the GTPases with RacV12,N33 did not inter-
fere with cell spreading. Expression of these mutants was
confirmed by Western blot analysis (data not shown). Interest-
ingly, coexpression of the constitutively activated mutants
RhoV14, ARF6(Q67L), and to a lesser extent Cdc42V12 in-
FIG. 2. Rac-induced spreading on immobilized fibronectin is integrin medi-
ated. RacV12,N33-transfected Jurkat cells were pretreated with either anti-b1 (5
mg/ml), anti-a4 (5 mg/ml), or anti-a5 (10 mg/ml) antibodies or control IgG for 30
min and then seeded on coverslips coated with 20 mg of full-length fibronectin
(A), p100FN (B), or p33FN (C) per ml. The data are representative of three
separate experiments.
TABLE 1. Quantitation of adhesion and spreading of cells
transfected with RacV12,N33
Transfectant
Avg no. of cells
adhered/field 6 SDa
Total adherent cells Spread cells
RacV12,N33 204 6 27 77 6 25
pcDNA3 144 6 30 0
RacV12N33 1 cytochalasin Db 156 6 29 3
a Jurkat cells (2 3 103) transfected with the indicated plasmids were seeded
onto 35-mm-diameter fibronectin-coated dishes; 16 h posttransfection, unat-
tached cells were rinsed off, and the total number of adherent cells (including
spread cells) and the total number of spread cells were determined. Cells exhib-
iting a flat fibroblast-like morphology were counted as spread cells. Each value
represents an average of eight fields.
b RacV12,N33-transfected cells were pretreated with cytochalasin D prior to
seeding on fibronectin-coated dishes.
VOL. 18, 1998 ROLE OF Rac IN T-CELL ADHESION 3939
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FIG. 3. Rac-induced spreading is accompanied by cytoskeletal rearrangements. (A) Effect of cytochalasin D on Rac-induced spreading. Jurkat cells were transfected
with 5 mg of an expression plasmid encoding RacV12,N33 (a, b, and d) or vector alone (c), plated on fibronectin-coated coverslips, and stained with anti-T7 antibodies
(a) or phalloidin (b to d). The RacV12,N33-transfected cells in panel d were pretreated with cytochalasin D (100 ng/ml) prior to seeding on fibronectin-coated
coverslips. Bar 5 10 mm. (B) Effects of activated RhoV14, ARF6(Q67L), Cdc42V12, H-RasV12, and RacV12 on RacV12,N33-induced spreading on immobilized
fibronectin. T7 epitope-tagged RacV12,N33 (5 mg) was cotransfected with expression plasmids encoding the indicated GTPases (10 mg of each) and seeded on
fibronectin-coated coverslips. Cells were viewed under a light microscope, and images were taken with a Canon camera. Bar 5 10 mm. (C) Effects of constitutively
activated mutant GTPases (as in panel B) on RacV12,N33-elicited cytoskeletal rearrangements. Jurkat cells transfected with indicated expression plasmids were seeded
on fibronectin-coated coverslips. To visualize actin structures, cells were fixed and labeled with rhodamine phalloidin. (D) Effects of Cdc42V12, RhoV14, and
ARF6(Q67L) on the cytoskeleton in T cells. Jurkat cells were transfected with T7 epitope-tagged expression plasmids encoding activated mutant forms of Cdc42, Rho,
and ARF6 and plated on fibronectin-coated dishes; 16 h posttransfection, cells were fixed and stained with either anti-T7 (b), anti-Rho (d), anti-ARF6 (f), or rhodamine
phalloidin (a, c, and e). Bar 5 10 mm. (E) Expression of RacV12,N33 and activated mutant GTPases. Lysates of cells expressing RacV12,N33 together with empty vector
(lane 1), RhoV14 (lane 2), ARF6(Q67L) (lane 3), Cdc42V12 (lane 4), H-RasV12 (lane 5), or RacV12 (lane 6) were subjected to SDS-PAGE, transferred to
nitrocellulose membranes, and immunoblotted with anti-Rac antibody. The same filter was stripped, cut, and immunoblotted with anti-Rho (lane 7), anti-ARF6 (lane
8), anti-T7 (lane 9), and anti-H-Ras (lane 10) antibodies.
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hibited RacV12,N33-induced spreading (Fig. 3B). Notably, co-
expression of the mutants with RacV12,N33 resulted in char-
acteristic cytoskeletal rearrangements distinct from the
RacV12,N33 spread phenotype or when RacV12 was coex-
pressed with RacV12,N33 (Fig. 3C). The effect on the cytoskel-
eton on expression of RhoV14, ARF6(Q67L), or Cdc42V12
alone is shown in Fig. 3D. The minor changes in cytoskeletal
organization elicited upon coexpression with H-RasV12 did
not alter the RacV12,N33-induced spread phenotype (Fig. 3B
and C). Western blot analysis showed that the level of
RacV12,N33 expression was not altered on coexpression of the
different GTPases mentioned above (Fig. 3E). Although acti-
vated mutant forms of Rho, ARF6, and Cdc42 triggered cy-
toskeletal rearrangements, none of them were able to induce
T-cell spreading on fibronectin. Thus, these data suggest that
cytoskeletal rearrangements which accompany T-lymphocyte
spreading on immobilized fibronectin are triggered exclusively
by Rac and not by the other GTPases investigated. The Rac-
induced spreading was energy dependent since this phenotype
was not observed by treatment of the cells with 2-deoxyglu-
cose–azide, an energy-depleting system. Also, pretreatment of
RacV12,N33-expressing cells with nocodazole had no effect,
indicating that cell spreading was independent of microtubule
assembly (see Fig. 7C).
It was previously reported that increased adhesion of leuko-
cytes may also be regulated through integrin clustering (9, 45,
51). To examine whether RacV12,N33 induces clustering of
the a4 and a5 integrins, RacV12,N33-expressing cells were
stained with antibodies against a4 and a5. As shown in Fig. 4,
clustering of a4 and a5 integrin receptors was indeed observed
at sites of cell attachment in the RacV12,N33-expressing cells,
as opposed to control transfected cells. The observation that
integrin staining appears more prominent in the spread, flat-
tened RacV12,N33-transfected cells than in the spherical con-
trol cells does not reflect a higher level of integrins present on
RacV12,N33-transfected cells (as shown below) but is due to
the presence of clustered integrins in these cells, which results
in brighter peripheral staining compared to the more dispersed
staining of integrins in control cells. Along with integrins, focal
adhesion proteins such as vinculin and paxillin were also found
at sites of attachment (data not shown). These findings suggest
that clustering of integrin receptors may contribute to Rac’s
ability to mediate T-cell adhesion. This distribution of integrin
receptors was not observed in RacV12,N33-expressing cells
that were treated with cytochalasin D (data not shown).
Expression of Rac does not alter expression levels or the
affinity state of the integrin receptors. Although the above
results suggest that Rac’s effect on T-cell adhesion is depen-
dent on cell spreading, we could not exclude the possibility that
the Rac-promoted T-cell adhesion onto immobilized fibronec-
tin is due in part to an increase in the level of expression of
integrin receptors at the cell surface or to an increase in affinity
of the receptors for fibronectin. To examine whether expres-
sion of Rac altered the surface integrin levels, Jurkat cells were
cotransfected with RacV12,N33 or empty vector and an ex-
pression plasmid encoding the cell surface marker CD20. After
24 h, the cells were harvested and analyzed by flow cytometry
for expression of CD20 (to identify transfected cells) and of a4,
a5, b1, and CD69, using antibodies against these proteins (Fig.
5). The results revealed that the surface expression of a4, a5,
and b1 integrins in RacV12,N33-transfected cells was similar
to that of control cells transfected with vector alone. It was
previously shown that the activated mutant form of Rac,
RacV12, triggered CD69 expression (25). Consistent with pre-
vious data, we observed that RacV12,N33 induced CD69 an-
tigen expression, indicating that the level of RacV12,N33 ex-
pression, using our transfection conditions, is sufficient to
trigger CD69 expression. To determine whether Rac could
modulate integrin affinity, we tested by fluorescence-activated
cell sorting analysis the ability of RacV12,N33-transfected cells
to bind to MAb 15/7, which interacts selectively with b1 inte-
grins in the high-affinity state (57). Jurkat cells cotransfected
with RacV12,N33 or empty vector and the CD20 expression
plasmid were stained for CD20 expression and assessed for
15/7 binding. As a positive control, we pretreated vector trans-
fected cells with MAb 8A2, previously shown to induce the
high-affinity state of b1 integrins (30). As shown in Fig. 6A,
which represents binding of CD20-positive cells to MAb 15/7,
cells treated with MAb 8A2 were recognized by 15/7, whereas
cells expressing RacV12,N33 were not. To assess whether the
integrin receptors were locked in an inactive conformation in
RacV12,N33-transfected cells, we tested for the ability of
RacV12,N33-transfected cells pretreated with MAb 8A2 to
bind to 15/7. We observed that 8A2 was still able to induce a
high-affinity state of b1 integrins on RacV12,N33-transfected
cells (Fig. 6A). In addition, we tested for the ability of cells
transfected with RacV12,N33 or with vector alone, or cells
treated with 8A2, to bind to 125I-labeled soluble fibronectin. As
shown in Fig. 6B and C, cells pretreated with 8A2 bound
soluble fibronectin, whereas RacV12,N33-transfected cells did
not. Moreover, the same basal-level binding profile was ob-
served for RacV12,N33-transfected cells as for empty vector-
transfected cells (Fig. 6B). Taken together, the above results
FIG. 4. Rac induces integrin clustering. RacV12,N33 (c to f)- or vector DNA
(a and b)-transfected cells were seeded on fibronectin-coated coverslips, fixed,
and stained with either anti-a4 (a and c) or anti-a5 (e) antibodies or with
rhodamine phalloidin (b, d, and f) to visualize actin organization. Bars 5 10 mm.
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suggest that Rac exerts its effect on T-cell adhesion through
events following receptor occupancy, such as cell spreading
and possibly integrin clustering, rather than alterations of in-
tegrin affinity or cell surface expression.
Rac-mediated spreading and adhesion appear to involve a
phospholipid kinase. Rac has been shown to regulate mul-
tiple biological activities including actin polymerization, acti-
vation of the JNK cascade, cell proliferation, and invasion (49).
The isolation and characterization of Rac mutants such as
RacV12,L37, RacV12,H40, and RacV12,N33 have aided in
delineating the signaling pathways conveying the cellular re-
sponses induced by Rac (28, 32, 55). The RacV12,L37 mu-
tant has been shown to induce PAK and JNK kinase acti-
vation but not membrane ruffling and cell transformation. The
RacV12,H40 mutant, on the other hand, does not stimulate
PAK and JNK activity but retains the ability to induce mem-
brane ruffling and transformation (28). The RacV12,N33 mu-
tant used for the studies described above is capable of inducing
cytoskeletal rearrangements and activates PAK and JNK ki-
nases but is impaired in SRF activation (55). Consistent with
the data obtained for COS and fibroblast cells, we observed
that in Jurkat cells, RacV12,L37 and RacV12,N33 mutants but
not RacV12,H40 were able to induce JNK activity (data not
shown). To gain additional insight into the signaling pathways
that regulate Rac-mediated cell spreading, we tested the Rac
mutants RacV12,L37 and RacV12,H40 (Fig. 7A). RacV12,L37-
expressing cells did not spread on immobilized fibronectin,
whereas the expression of RacV12,H40 induced cell spreading
onto immobilized fibronectin, to an extent similar to RacV12.
Expression of the Rac mutants was confirmed by immunoblot-
ting (Fig. 7B). These results indicate that the ability of Rac to
induce T-cell spreading is controlled by pathways leading to
FIG. 5. Flow cytometry analysis of a4, a5, b1, and CD69 expression in Jurkat cells. Cells transfected either with 10 mg of RacV12,N33 or 10 mg of control empty
vector and 2 mg of vector expressing the CD20 marker were analyzed for a4, a5, b1, and CD69 expression on the total amount of cells that survived electroporation
(upper two panels) or on CD20-positive cells (lower two panels). The left peak in the upper panels represent cells treated with FITC-labeled secondary antibody alone.
RacV12,N33 induces CD69 antigen expression but not the expression of a4, a5, or b1 integrins.
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cytoskeletal rearrangements and is independent of PAK, JNK,
and SRF activation. The Rac-induced spreading was also in-
dependent of pp70S6 kinase since rapamycin, a specific inhibitor
of this enzyme, had no effect on cell spreading (Fig. 7C).
pp70S6 kinase was previously shown to interact with and be
activated by Rac and Cdc42 (11). Interestingly, the drug wort-
mannin dramatically reduced Rac-mediated spreading at a
concentration of 50 nM. Similarly, pretreatment of RacV12,
N33-expressing cells with 100 mM LY294002 inhibited their
ability to spread on immobilized fibronectin (Fig. 7C). Al-
though lower concentrations of LY294002 (25 or 50 mM) or
wortmannin (25 nM) have previously been shown to interfere
with most of the cellular responses mediated by PI3-kinase,
these concentrations did not inhibit RacV12,N33-induced
spreading. To further explore a potential role of PI3-kinase in
Rac-induced T-cell spreading, we tested whether a constitu-
tively active, membrane-targeted PI3-kinase (p110a-CAAX)
was able to mimic RacV12,N33-induced cell spreading. We
could not observe any cell spreading on expression of consti-
tutively active PI3-kinase at concentrations between 5 to 25 mg
(data not shown). These data suggest that PI3-kinase is most
likely not the kinase responsible for mediating Rac’s effect on
T-cell spreading. Potential candidates are the more recently
identified novel lipid kinases which appear to be sensitive only
to higher concentrations of wortmannin and LY294002.
DISCUSSION
The importance of T-cell adhesion is reflected by several
inflammatory disorders resulting from abnormalities in this
process. Successful adhesion appears to require a combination
of sufficient high-affinity receptors and postreceptor events in-
volving cell spreading and/or integrin clustering (7, 16, 45, 46).
However, the signaling pathways involved in T-cell adhesion
remain elusive. Recently, a few signaling molecules, such as
calreticulin, R-Ras, and H-Ras, have been demonstrated to be
important for the modulation of integrin affinity for their li-
gands (12, 23, 58). R-Ras was reported to promote ligand
binding affinity of integrin receptors, whereas H-Ras was
shown to decrease the ligand binding affinity (23, 58). Our
study demonstrates that Rac promotes integrin-mediated T-
lymphocyte–ECM adhesion by triggering cell spreading rather
than by altering the receptor affinity, and to our knowledge it
is the first signaling molecule identified in this process. Inter-
estingly, Rac has recently been reported to contribute to E-
cadherin-mediated adhesion in MDCK cells and keratinocytes
(8, 21, 48). A role for Rac in motility and invasion of fibroblasts
and epithelial cells has also been reported (4, 29, 43). We
provide two lines of evidence that demonstrate the importance
of actin polymerization and cytoskeletal rearrangements in
FIG. 6. Rac-induced spreading and adhesion are not dependent on changes
in the affinity state of integrin receptors. (A) The activation-dependent antibody
15/7 does not bind to RacV12,N33-expressing cells. Jurkat cells cotransfected
with 10 mg of pCGT-RacV12,N33 or empty vector and 2 mg of vector expressing
the CD20 marker were untreated or treated with the activating MAb 8A2 and
stained for CD20 expression and 15/7 binding. (B and C) Ten micrograms of
pCGT-RacV12,N33 or vector alone and cells treated with MAb 8A2 were incu-
bated with 125I-labeled fibronectin (FN) (B). RacV12,N33- and vector-trans-
fected cells were incubated with 125I-labeled fibronectin in the absence or pres-
ence of increasing concentrations of unlabeled fibronectin for 1 h (C). The latter
represents an average of three experiments; each data point plotted is the mean
of duplicate samples. The amount of radiolabeled fibronectin bound to the cells
was quantitated as described in Materials and Methods.
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Rac-induced T-cell spreading. First, treatment of cells with
cytochalasin D inhibited Rac-elicited spreading and increased
adhesion on immobilized fibronectin. Second, coexpression of
activated mutant forms of ARF6, Rho, and Cdc42 abolished
Rac-induced T-cell spreading, most likely through their effect
on the cytoskeleton, since all three GTPases caused a dramatic
change of the cytoskeletal organization of RacV12,N33-ex-
pressing cells. The effects of Cdc42, Rac, and Rho on the
cytoskeleton in macrophages and monocytes have recently
been described (3). These cell types, like T cells, do not possess
stress fibers as seen in fibroblasts. Cdc42 and Rac were shown
to induce filopodium formation and the formation of lamelli-
podia and membrane ruffles, respectively, whereas Rho elic-
ited actin redistribution and the cells assumed a rounded con-
tracted phenotype (3). Similarly, we observed the formation of
filopodium-like structures and a more contracted phenotype
on expression of activated mutant forms of Cdc42 and Rho,
respectively, in Jurkat cells. Notably, activated mutant forms of
neither ARF6, Cdc42, nor Rho induced T-lymphocyte spread-
ing on immobilized fibronectin, indicating that the cytoskeletal
rearrangement required for T-cell spreading was restricted to
the Rac GTPase. Consistent with our observation that coex-
pression of activated Rho abolished Rac-induced spreading
and adhesion was the report by Aepfelbacher et al., in which
Rho was demonstrated to be a negative regulator of human
monocyte spreading by maintaining cell tension and cortical
actin organization (1). More recently Rac has been shown to
promote neurite outgrowth of N1E-115 neuroblastoma cells
(52). The observations that an activated mutant form of Rac
prevented LPA-induced neurite retraction and that a domi-
nant negative mutant form of Rho mimicked the phenotype of
RacV12 suggest that Rac may act by antagonizing Rho func-
FIG. 7. (A) Effects of the Rac mutants RacV12,H40, RacV12,L37, and RacV12,N33 on T-cell spreading. Jurkat cells transfected with 5 mg of expression plasmids
encoding either RacV12,H40, RacV12,L37, or RacV12,N33 were seeded on fibronectin-coated tissue culture dishes. Six hours posttransfection, cells were visualized
with a light microscope and photographed with a Canon camera. (B) Expression of the Rac mutant proteins. Lysates of the cells expressing RacV12,H40, RacV12,L37,
and RacV12,N33 were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with anti-T7 antibody. (C) Effects of pharmacological
agents on RacV12,N33-mediated spreading. RacV12,N33-transfected Jurkat cells were pretreated with 50 mM 2-deoxyglucose–0.04% sodium azide (DOG-azide),
nocodazole (1 mM), rapamycin (50 ng/ml), wortmannin (50 nM), and LY294002 (100 mM) for 30 min and seeded on fibronectin-coated coverslips. After 2 h, spread
cells were counted. The data are representative of three separate experiments.
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tion. However, we did not observe T-cell spreading on expres-
sion of a dominant negative mutant of Rho, indicating that the
Rac does not exert its effect on T-cell spreading by antagoniz-
ing Rho function.
Clustering of integrin molecules is thought to enhance inte-
grin-ligand interaction through multivalent interactions with
ligand without an alteration in the affinity of the integrin for
the ligand (9, 45, 51). Our data show that expression of con-
stitutively active Rac triggers the clustering of a4b1 and a5b1
integrins. It was previously reported that clustering of LFA-1
facilitates the binding of interleukin-2–phytohemagglutinin-ac-
tivated peripheral blood lymphocytes (PBLs) to ICAM-1, and
that the actin cytoskeleton maintains LFA-1 in a clustered
(high-avidity) state on activated PBLs and in a homogeneously
distributed state in resting PBLs (33). In contrast, it was re-
ported that b1-mediated adhesion was inhibited when actin
polymerization was inhibited (33). It is possible therefore that
clustering of a4b1 and a5b1 integrins in RacV12,N33-express-
ing cells is dependent on Rac-elicited cytoskeletal rearrange-
ments. Our results also demonstrate that Rac does not induce
an alteration in the affinity state of the integrin receptors.
Interestingly, although H-Ras was recently shown to suppress
the transition of b1 integrins to the high-affinity state (23),
coexpression of activated H-Ras with RacV12 did not abolish
the ability of RacV12-expressing cells to spread and adhere on
immobilized fibronectin. These findings support the fact that
RacV12-mediated T-cell adhesion is not dependent on alter-
ations of the affinity state of the integrins.
It has been well documented that phorbol esters (phorbol
myristate acetate [PMA]) induce T-cell adhesion without any
measurable change in the affinity for soluble fibronectin but by
an increase in cell spreading (16, 54). However, PMA-induced
spreading of Jurkat cells is not mediated by Rac since the
dominant negative mutant form of Rac does not interfere with
PMA-induced spreading on immobilized fibronectin (unpub-
lished observations). Natural agonists, such as the chemokine
MIP-1a and the cell surface receptor CD3, have been demon-
strated to promote VLA-4-mediated adhesion to VCAM with-
out altering the integrin affinity state (27). Hence, of particular
interest in the future will be the identification of extracellular
agonists which trigger Rac-induced cell spreading.
To obtain more insight in the downstream signaling path-
ways mediating Rac-induced cell spreading, we made use of
the previously characterized Rac effector mutants (28, 55). Our
results indicate that activation of JNK or SRF is not sufficient
or required for Rac-induced spreading since (i) the RacV12,H40
mutant, defective in JNK activation, was still able to induce
spreading, whereas the RacV12,L37 mutant, which is still able
to induce JNK activation, failed to induce spreading and (ii)
the RacV12,N33 mutant, which is the most potent for the
induction of cell spreading, was significantly impaired in SRF
activation. Furthermore, the lack of inhibition of T-cell spread-
ing by the drug rapamycin (inhibitor of pp70S6 kinase) excluded
S6 kinase as a potential mediator of the Rac-elicited pheno-
type. We observed that wortmannin and LY294002 (at con-
centrations of 50 nM and 100 mM, respectively) did interfere
with the ability of RacV12,N33 to induce T-cell spreading on
immobilized fibronectin, suggesting the involvement of a lipid
kinase downstream of Rac. The lipid kinase activities of most
of the PI3-kinase enzymes (including p110a -b, -g, and -d)
were found to exhibit comparable sensitivities to inhibition by
wortmannin and LY294002 (50% inhibitory concentrations of
5 nM and 0.5 mM, respectively) (37, 50). LY294002, at a con-
centration of 25 mM, has been demonstrated to block most
cellular responses mediated by PI3-kinase, including platelet-
derived growth factor-induced membrane ruffling (41). Our
observations that inhibition of RacV12,N33-induced spreading
can be obtained by using this drug at a concentration of 100
mM but not lower and that a constitutively active form of
PI3-kinase cannot mimic RacV12-induced cell spreading sug-
gest that lipid kinases other than PI3-kinase may be responsi-
ble for mediating Rac’s effect on T-cell spreading. In light of
this, several PI4-kinases (referred to as type III PI4 kinases)
have recently been identified and shown to be sensitive to
wortmannin and LY294002, although at concentrations higher
than those required to inhibit PI3-kinase in vitro (5, 13, 34, 35,
56). Further experiments will be required to define the lipid
kinase mediating Rac-induced T-cell spreading.
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